Cointime

Neuroene Therapeutics

company

About

Neuroene Therapeutics is a startup biotechnology company.

  • 11 - 50

Highlights

Total Funding Amount
$1.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Neuroene Therapeutics is a startup biotechnology company developing novel Vitamin K-based therapeutics for neurological disorders such as epilepsy. The company originated from collaborative research between Medical University of South Carolina investigators C. James Chou, Ph.D., and Sherine Chan, Ph.D., who cofounded and continue to lead Neuroene Therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.50M
Neuroene Therapeutics has raised a total of $1.50M in funding over 2 rounds. Their latest funding was raised on Oct 29, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 29, 2018 Grant $1.50M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Neuroene Therapeutics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท